Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2012 | 03-2012 | 03-2011 | 09-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,882 | 17,035 | 16,072 | 15,780 | 26,640 |
| Marketable Securities | N/A | N/A | N/A | N/A | 27,485 |
| Other current assets | 320 | 67 | 0 | 18 | 8 |
| TOTAL | $21,288 | $17,470 | $16,091 | $15,798 | $54,133 |
| Non-Current Assets | |||||
| PPE Net | 26,706 | 492 | N/A | 0 | N/A |
| Intangibles | 1,385 | 24,236 | N/A | 0 | N/A |
| TOTAL | $28,091 | $24,727 | $0 | $0 | $0 |
| Total Assets | $49,379 | $42,198 | $16,091 | $15,798 | $54,133 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 85 | 493 | 42 | N/A | 80 |
| TOTAL | $484 | $833 | $79 | $40 | $80 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | -24 | 0 | 0 | 0 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $484 | $833 | $79 | $40 | $80 |
| Shareholders' Equity | |||||
| Retained earnings | -48,721 | -29,647 | -9,542 | -9,207 | 28,964 |
| Other shareholders' equity | 1,400 | 802 | 156 | 0 | 2,114 |
| TOTAL | $48,895 | $41,341 | $16,012 | $15,758 | $54,053 |
| Total Liabilities And Equity | $49,379 | $42,174 | $16,091 | $15,798 | $54,133 |